We used CRISPR to Make 15 Point Mutations in 5 Genes
Here’s what we learned
As geneticists, we are naturally curious about how efficient CRISPR is. Recently, we took a step back to review the stats on point mutations we’ve created. Here’s a list of our big takeaways about how CRISPR gene editing is working for us
Featured Findings:
- Longevity studies using C. elegans to identify potential anti-aging compound [Customer Story]
- Dr. David Vollmer, Chief Scientific Officer at the dietary supplement company 4Life Research, needed to understand whether a particular ingredient in a new supplement product had anti-aging effects, and to examine the mechanism and science behind the effects.
Read his story
- Dr. David Vollmer, Chief Scientific Officer at the dietary supplement company 4Life Research, needed to understand whether a particular ingredient in a new supplement product had anti-aging effects, and to examine the mechanism and science behind the effects.
- 17 Minutes of Science: Removing Language Barriers & Making Science More Accessible
- Join us as we discuss with Karol Andrade about how she is making science more accessible to those in her community and beyond by removing language barriers in scientific communications.
Watch the interview
- Join us as we discuss with Karol Andrade about how she is making science more accessible to those in her community and beyond by removing language barriers in scientific communications.
- Research Spotlight: Alzheimer’s Disease
- June is Alzheimer’s & Brain Awareness Month. We wanted to take a few moments to spotlight some of the awe-inspiring research on Alzheimer’s disease taking place in alternative animal models.
Read more
- June is Alzheimer’s & Brain Awareness Month. We wanted to take a few moments to spotlight some of the awe-inspiring research on Alzheimer’s disease taking place in alternative animal models.
- 17 Minutes of Science: Viral gene therapies and their potential use against COVID-19
- Join us as we talk with Mark Mendoza about viral gene therapies, which have a plethora of applications for healthcare, and are currently being looked at as an option in the fight against COVID-19.
Watch the interview
- Join us as we talk with Mark Mendoza about viral gene therapies, which have a plethora of applications for healthcare, and are currently being looked at as an option in the fight against COVID-19.
- A View From the Bench: Roadblocks and Frustrations When Expectation Meets Reality
- In an effort to create better models for epilepsy, we’ve been working on a grant-funded project to humanize important synaptic machinery by replacing endogenous coding sequences with human coding sequences.
Read more
- In an effort to create better models for epilepsy, we’ve been working on a grant-funded project to humanize important synaptic machinery by replacing endogenous coding sequences with human coding sequences.
Industry News:
- CRSIPR/Cas9 market to grow significantly from 2020 to 2026, North America to be major revenue contributor
- Genome editing market research, industry outlook, current trends and forecast by 2025
- Zebrafish study reveals some of us might feel anxious trying to socialize after lockdown
- For some biotech employees in the age of COVID-19, the workday starts at the bathroom sink
- Combatting racial inequality in aging research
P.S.
Have you tuned in to our weekly series, 17 Minutes of Science? It happens weekly on Tuesdays at 11am PT / 2pm ET. You can watch past episodes here or check out who we’ll be interviewing next week here (hint: she works with sharks!).